MAT1A protein: the core enzyme of hepatic methyl donor synthesis and a metabolic hub of epigenetic regulation

Author: Senior Product Manager of UA Views：9

This article focuses on the molecular characteristics and biological functions of methionine adenosyltransferase 1A (MAT1A), systematically elaborating its enzymatic mechanism and structural basis as the primary producer of SAM catalyzing the synthesis of S-adenosylmethionine from methionine and ATP, analyzing the epigenetic consequences of formaldehyde exposure leading to reduced SAM content and loss of histone methylation through inhibition of MAT1A, and exploring the clinical significance of MAT1A silencing due to promoter hypermethylation in hepatocellular carcinoma and cholangiocarcinoma, as well as the therapeutic potential of restoring MAT1A expression or supplementing SAM.

Recent Advances
Product Information

Recent Advances

MAT1A Protein: The Core Enzyme of Hepatic Methyl Donor Synthesis and a Metabolic Hub of Epigenetic Regulation

Summary: This article focuses on the molecular characteristics and biological functions of methionine adenosyltransferase 1A (MAT1A), systematically describing its enzymatic mechanism and structural basis as the major producer of SAM that catalyzes the synthesis of S-adenosylmethionine from methionine and ATP, analyzing the epigenetic consequences of formaldehyde exposure inhibiting MAT1A and thereby leading to reduced SAM content and loss of histone methylation, and discussing the clinical significance of MAT1A silencing in hepatocellular carcinoma and cholangiocarcinoma due to promoter hypermethylation as well as the therapeutic potential of restoring MAT1A expression or supplementing SAM.

I. Molecular Structure and Liver Tissue Specificity of MAT1A.

MAT1A is mainly expressed in the liver, and the encoded protein exists as dimers or tetramers, with each subunit containing approximately 395 amino acids and possessing a typical Rossmann fold nucleotide-binding domain and a catalytic domain. The Rossmann fold is a structural motif shared by many enzymes that use nucleotides as coenzymes, and its core function is to bind nucleotide ligands such as ATP and correctly position the reactive groups. The high expression of MAT1A in the liver makes it a core node of hepatic one-carbon metabolism——the liver is the central organ for the synthesis and distribution of methyl donors in the body, and the expression level of MAT1A directly determines the SAM supply capacity of the liver and even the whole body.

II. Enzymatic Function and Metabolic Position of MAT1A in Catalyzing SAM Synthesis.

Functionally, MAT1A catalyzes the synthesis of S-adenosylmethionine from methionine and ATP, serving as the core enzyme of hepatic one-carbon metabolism and methylation reactions. SAM is the universal donor of the chemical group “methyl” that regulates epigenetic activity, and almost all methylation reactions——including DNA methylation, histone methylation, and the methylation of various small-molecule metabolites——use SAM as the methyl source. Therefore, the activity status of MAT1A directly determines the donor pool capacity for intracellular methylation reactions, and its functional downregulation will trigger a multi-level cascade of effects from metabolism to epigenetics. This metabolic position of “a single enzyme determining the supply of a universal donor” makes MAT1A a key hub connecting nutritional metabolism and gene expression regulation.

III. Inhibition of MAT1A by Formaldehyde and Its Epigenetic Consequences.

Formaldehyde is an inhibitor of the MAT1A protein. Specifically, exposure to formaldehyde leads to reduced SAM content and causes the loss of histone methylation, and histones are proteins that package DNA and control the functions of thousands of genes. The elucidation of this mechanistic chain has important toxicological significance: formaldehyde, as a widely present environmental pollutant and intracellular metabolic byproduct, inhibits MAT1A not merely by altering metabolic flux, but further transmits the effect through SAM depletion to the level of histone methylation, affecting chromatin structure and gene expression programs. The number of genes affected by the loss of histone methylation can reach thousands, which means that the epigenetic effects of formaldehyde exposure are extensive and potentially persistent, far exceeding the traditional understanding of it as a simple irritant.

IV. Silencing Mechanism and Prognostic Value of MAT1A in Liver Cancer.

Clinically, MAT1A is often silenced in hepatocellular carcinoma and cholangiocarcinoma due to promoter hypermethylation, leading to SAM depletion, DNA hypomethylation, and genomic instability, which promote tumor progression. This mechanism presents a noteworthy circular logic: the silencing of MAT1A originates from promoter hypermethylation, and promoter hypermethylation itself depends on SAM as a methyl donor; when the loss of MAT1A function leads to SAM depletion, further methylation modifications should theoretically be weakened, but tumor cells maintain abnormal methylation patterns through other pathways, ultimately forming a malignant phenotype of DNA hypomethylation and genomic instability. The expression ratio of MAT1A to MAT2A can serve as a prognostic marker for liver cancer, and restoring MAT1A expression or supplementing SAM has therapeutic potential. MAT2A is another member of the MAT family and is often compensatorily upregulated in tumor cells; changes in the MAT1A-to-MAT2A expression ratio reflect the transition of hepatic methyl metabolism from a normal pattern to a tumor pattern, and thus have prognostic value.

V. MAT1A Mutations and Functional Regulation in Alcoholic Liver Disease.

In addition, MAT1A mutations can cause methionine adenosyltransferase I/III deficiency, namely hypermethioninemia, and this inherited disease phenotype directly demonstrates the pathological consequences of MAT1A loss of function in humans. In the pathogenesis of alcoholic liver disease, alcohol promotes MAT1A degradation through phosphorylation and SUMOylation, leading to decreased SAM synthesis capacity and further aggravating hepatic methylation imbalance and injury. This finding links the regulation of MAT1A protein stability with the molecular pathology of alcoholic liver disease, suggesting that MAT1A is not only a metabolic enzyme but also an unstable protein precisely regulated by post-translational modifications, and that changes in its degradation rate can significantly affect the state of hepatic methyl metabolism.

VI. Conclusion.

In basic research related to MAT1A and drug development for liver diseases, high-quality recombinant MAT1A protein is a core tool for dissecting its catalytic mechanism, evaluating inhibitor effects, and conducting enzyme kinetics studies. The His tag facilitates efficient purification by immobilized metal affinity chromatography and enables detection and capture with anti-His tag antibodies. To meet the needs of MAT1A function research and exploration of the mechanisms of liver metabolic diseases, Ulab provides MAT1A His Tag Protein, Human. This product is suitable for applications such as enzyme activity assays of MAT1A-catalyzed synthesis of SAM from methionine and ATP, in vitro evaluation of the inhibitory effects of exogenous factors such as formaldehyde and alcohol on MAT1A, functional and stability analysis of MAT1A mutants, and the development of therapeutic strategies related to restoring MAT1A expression or supplementing SAM.

This article is reviewed and published by the technical expert team of UA

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Nanjing Univ is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.

Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience

Nanjing UNIV Biotechnology Co., Ltd. Email：order@ua-bio.com Phone：+86-25-56221161

more products

Product Information

The Last The Next